Epidemiology of extra-pulmonary tuberculosis in the United States: High rates persist in the post-HIV era

International Journal of Tuberculosis and Lung Disease

Volumn 18, Issue 12, 2014, Pages 1516-1521

  Adada, H ^a   Valley, M A ^a   Nour, S A ^a   Mehta, J ^a   Byrd, R P ^a   Anderson, J L ^a   Roy, T ^a  

^a EAST TENNESSEE STATE UNIVERSITY   (United States)

Author keywords

Epidemiology; Extra pulmonary TB; Tuberculosis

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; CONTROLLED STUDY; EXTRAPULMONARY TUBERCULOSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMIGRATION; INCIDENCE; LUNG TUBERCULOSIS; TREND STUDY; UNITED STATES; AGE; CHI SQUARE DISTRIBUTION; EPIDEMIC; HIV INFECTIONS; IMMUNOCOMPROMISED PATIENT; IMMUNOLOGY; MIGRANT; MIXED INFECTION; POPULATION RESEARCH; PUBLIC HEALTH SERVICE; RISK FACTOR; STATISTICAL MODEL; TIME; TUBERCULOSIS;

IMMUNOSUPPRESSIVE AGENT;

AGE DISTRIBUTION; AGE FACTORS; CENSUSES; CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); CHI-SQUARE DISTRIBUTION; COINFECTION; EMIGRANTS AND IMMIGRANTS; EPIDEMICS; HIV INFECTIONS; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; LINEAR MODELS; RISK FACTORS; TIME FACTORS; TUBERCULOSIS; UNITED STATES;

EID: 84911368371     PISSN: 10273719     EISSN: 18157920     Source Type: Journal    
DOI: 10.5588/ijtld.14.0319     Document Type: Article

References (31)

1. Centers for Disease Control and Prevention, National Center for HIV, STD and TB Prevention, Division of Tuberculosis Elimination. Reported tuberculosis in the United States, 1996 to 2012. Atlanta, GA, USA: CDC, 1990-2012. www.cdc.gov Accessed September 2014
2. Centers for Disease Control and Prevention. HIV and AIDS: United States, 1981-2000. MMWR Morb Mortal Wkly Rep 2001; 50: 430-434.
3. Cantwell M F, Snider D E, Cauthen G M, Onorato I M. Epidemiology of TB in the United States: 1985 through 1992. JAMA 1994; 272: 535-539.
4. Bloom B R, Murray C G L. Tuberculosis: Commentary on a reemergent killer. Science 1992; 257: 1055-1064.
5. Nelson C, Zunt J. Tuberculosis of the central nervous system in immunocompromised patients: HIV infection and solid organ transplant recipients. Clin Infect Dis 2011; 53: 915-926.
6. Miller E A, Ernst J D. Anti-TNF immunotherapy and tuberculosis reactivation: Another mechanism revealed. J Clin Invest 2009; 119: 1079-1082.
7. Atasever A, Bacakoglu F, Toz H, et al. Tuberculosis in renal transplant recipients on various immunosuppressive regimens. Nephrol Dial Transplant 2005; 20: 797-802.
8. Ward B W, Schiller J S. Prevalence of multiple chronic conditions among US adults. Estimates from the National Health Interview Survey. Prev Chronic Dis 2013: 10: E65.
9. Mehta J B, Dutt A, Harvill L, Mathews K M. Epidemiology of extra-pulmonary TB: A comparative analysis with pre-AIDS era. Chest 1991; 99: 1134-1138.
10. North S N D. Mortality statistics: 1900 to 1904. Washington DC, USA: Bureau of the Census, Department of Commerce and Labor, 1906: P 33.
11. Kung H C, Hoyert D L, Xu J, Murphy S L. Deaths: Final data for 2005. Natl Vital Stat Rep 2008; 56: 31.
12. Bureau of the Census. Historical national population estimates: July 1, 1900 to July 1, 1999. Washington DC, USA: Bureau of the Census, 2000. http: //www.census.gov/popest/data/national/totals/pre-1980/tables/popclockest.txt. Accessed August 2014.
13. US Census Bureau, Population Division. Table 1: Intercensal estimates of the resident population by sex and age for the United States: April 1, 2000 to July 1, 2010 (US-EST00INT-01). Washington DC, USA: US Census Bureau, 2011.
14. US Census Bureau, Population Division. Table 1: Monthly population estimates for the United States: April 1, 2010 to November 1, 2012. NA-EST2011-01-11. Washington DC, USA: US Census Bureau, 2012. http: //www.census.gov/popest/data/intercensal/national/nat2010.html. Accessed August 2014.
15. Hoefer M, Rytina N, Baker B C. Estimates of the size and characteristics of resident nonimmigrant population in the United States: January 2010. Population Estimates.Washington DC, USA: Policy Directorate, Office of Immigration Statistics, Department of Homeland Security, 2010.
16. Cain K P, Benoit S R, Winston C A, MacKenzie W R. Tuberculosis among foreign-born persons in the United States. JAMA 2008; 300: 405-412.
17. Daniel T. The impact of tuberculosis on civilization. Infect Dis Clin N Am 2004; 18: 157-165.
18. Havlir D V, Barnes P F. Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med 1999; 340: 367-373.
19. Maher D, Raviglione M. Global epidemiology of tuberculosis. Clin Chest Med 2005; 26: 167-182.
20. JohnsonMD, Decker C F. Tuberculosis and HIV infection. Dis Mon 2006; 52: 420-427.
21. Reported HIV status of tuberculosis patients: United States, 1993-2005. MMWR Morb Mortal Wkly Rep 56: 1103-1106.
22. Wendel K A, Alwood K S, Gachuhi R, Chaisson R E, Bishai W R, Sterling T R. Paradoxical worsening of tuberculosis in HIVinfected persons. Chest 2001; 120: 193-197.
23. Farer L S. Extra-pulmonary tuberculosis in the United States. Am J Emidemiol 1979; 109: 205-217.
24. US Immigration and Naturalization Service. Estimates of unauthorized immigrant population residing in the United States: 1990 to 2000. Washington DC, USA: Office of Policy and Planning, US Immigration and Naturalization Service, 2001.
25. Nwosu C, Batalova J, Auclair G. 04/28/2014 Newsletter. Washington DC, USA: Migration Policy Institute, 2014.
26. Schneider E, Moore M, Castro K G. Epidemiology of tuberculosis in the United States. Clin Chest Med 2005; 26: 183-195.
27. Sichletidis L, Settas L, Spyratos D, Chloros D, Patakas D. Tuberculosis in patients receiving anti-TNF agents despite chemoprophylaxis. Int J Tuberc Lung Dis 2006; 10: 1127-1132.
28. Keane J, Gershon S, Wise R P, et al. Tuberculosis associated with infliximab, a tumor necrosis factor a-neutralizing agent. N Engl J Med 2001; 345: 1098-1104.
29. Gardam M A, Keystone E C, Menzies R, et al. Anti-tumour necrosis factor agents and tuberculosis risk: Mechanisms of action and clinical management. Lancet Infect Dis 2003; 3: 148-155.
30. Miller V, Ranatunga S K M. Immunotherapies on rheumatologic disorders. Med Clin N Am 2012; 96: 475-496.
31. Johnson&Johnson. 2011 Annual Report. New Brunswick, NJ, USA: Johnson & Johnson, 2011. http: //www.investor.jnj.com/2011annualreport/pdf/2011-annual-report.pdf. Accessed August 2014.